National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 55973-55974 [2019-22710]

Download as PDF Federal Register / Vol. 84, No. 202 / Friday, October 18, 2019 / Notices 55973 TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. Title of collection Export of Medical Devices; Foreign Letters of Approval ......................................................................................... Registration of Food Facilities ................................................................................................................................. Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002 ..................................................................................................................................................................... Medical Device User Fee Cover Sheet—Form FDA 3601 ..................................................................................... Bar Code Label Requirement for Human Drug Products and Biological Products ................................................ Guidance on Reagents for Detection of Specific Novel Influenza A Viruses ......................................................... Guidance: Emergency Use Authorization of Medical Products and Related Authorities ....................................... Production, Storage, and Transportation of Shell Eggs (preventing Salmonella Enteritidis (SE)) ......................... Center for Devices and Radiological Health Appeals Processes ........................................................................... Food Labeling: Nutrition Facts Label and Supplement Facts Labels ..................................................................... Dated: October 10, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–22803 Filed 10–17–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Brain Tumors, Neuro-sequalae of Cancer Treatments and Neurodegeneration. Date: November 5, 2019. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Wei-Qin Zhao, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5181, MSC 7846, Bethesda, MD 20892, 301–827– 7238 zhaow@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; VerDate Sep<11>2014 16:37 Oct 17, 2019 Jkt 250001 Fellowships: Brain Disorders and Related Neurosciences. Date: November 7–8, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott-Residence Inn Bethesda, 7355 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040M, MSC 7806, Bethesda, MD 20892, 301–402– 7278, movsesyanv@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR17–094: Maximizing Investigators’ Research Award (R35). Date: November 12, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301–827–7088, methode.bacanamwo@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–22709 Filed 10–17–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Date approval expires 0910–0264 0910–0502 8/31/2022 8/31/2022 0910–0510 0910–0511 0910–0537 0910–0584 0910–0595 0910–0660 0910–0738 0910–0813 8/31/2022 8/31/2022 8/31/2022 8/31/2022 8/31/2022 8/31/2022 8/31/2022 8/31/2022 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel PAR–16–412: NIAID Resource-Related Research Projects (R24). Date: November 13, 2019. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute for Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Ann Marie M. Brighenti, Ph.D., Scientific Review Officer, Program Management and Operations Branch, Scientific Review Program, National Institute for Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, RM 3E71, Rockville, MD 20852, 301–761–3100, cruza@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\18OCN1.SGM 18OCN1 55974 Federal Register / Vol. 84, No. 202 / Friday, October 18, 2019 / Notices Dated: October 11, 2019. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–22710 Filed 10–17–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: February 5–6, 2020. Open: February 05, 2020, 12:30 p.m. to 6:00 p.m. Agenda: Report by the Director, NINDS; Report by the Director, Division of Extramural Activities; and Administrative and Program Developments. Closed: February 06, 2020, 8:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892. Contact Person: Robert Finkelstein, Ph.D., Director of Extramural Activities, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301) 496–9248, finkelsr@ninds.nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: May 27–28, 2020. Open: May 27, 2020, 12:30 p.m. to 6:00 p.m. VerDate Sep<11>2014 16:37 Oct 17, 2019 Jkt 250001 Agenda: Report by the Director, NINDS; Report by the Director, Division of Extramural Activities; and Administrative and Program Developments. And Overview of the NINDS Intramural Program. Closed: May 28, 2020, 8:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Closed: May 28, 2020, 12:30 p.m. to 1:00 p.m. Agenda: To review and evaluate the Division of Intramural Research Board of Scientific Counselors’ Reports. Place: National Institutes of Health, Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892. Contact Person: Robert Finkelstein, Ph.D., Director of Extramural Activities, National Institute of Neurological, Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301) 496–9248, finkelsr@ninds.nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: September 9–10, 2020. Open: September 09, 2020, 12:30 p.m. to 6:00 p.m. Agenda: Report by the Director, NINDS; Report by the Director, Division of Extramural Activities; and Administrative and Program Developments. Place: National Institutes of Health, Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892. Closed: September 10, 2020, 8:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892. Contact Person: Robert Finkelstein, Ph.D., Director of Extramural Activities, National Institute of Neurological, Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301) 496–9248, finkelsr@ninds.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 Dated: October 11, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–22712 Filed 10–17–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Pain Research Coordinating Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Interagency Pain Research Coordinating Committee. Date: November 18, 2019. Time: 8:30 a.m. to 5:00 p.m. Agenda: The meeting will include discussions of committee business items including information about the NIH HEAL Initiative and an update on the Pain Management Best Practices Interagency Task Force. Place: National Institutes of Health, Porter Neuroscience Research Center, Building 35A, Room 610, 35 Convent Drive, Bethesda, MD 20892. Webcast Live: https://videocast.nih.gov/. Deadlines: Submission of intent to submit written/electronic statement for comments: Monday, November 4, 2019. Submission of written/electronic statement for oral comments: Monday, November 11, 2019. Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain Policy & Planning, Office of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, Bethesda, MD 20892, Phone: (301) 451–4460, Email: Linda.Porter@nih.gov. Any member of the public interested in submitting written comments to the Committee must notify the Contact Person listed on this notice by 5:00 p.m. ET on Monday, November 4, 2019, with their request. Interested individuals and representatives of organizations must submit a written/electronic copy of the oral statement/comments including a brief description of the organization represented by 5:00 p.m. ET on Monday, November 11, 2019. Statements submitted will be shared with the committee members and become a part of the public record. E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 84, Number 202 (Friday, October 18, 2019)]
[Notices]
[Pages 55973-55974]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22710]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel PAR-16-412: NIAID Resource-Related 
Research Projects (R24).
    Date: November 13, 2019.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute for Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892 (Telephone Conference Call).
    Contact Person: Ann Marie M. Brighenti, Ph.D., Scientific Review 
Officer, Program Management and Operations Branch, Scientific Review 
Program, National Institute for Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, RM 3E71, 
Rockville, MD 20852, 301-761-3100, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 55974]]


    Dated: October 11, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-22710 Filed 10-17-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.